Molecular analysis of resistance to interferon in patients with laryngeal papillomatosis

Cytokines, Cellular and Molecular Therapy

Volumn 5, Issue 2, 1999, Pages 79-85

  García Milián, Rolando ^a,b   Santos, Alicia ^a   Perea, Silvio E ^a   González Cabañas, Rolando ^a   Valenzuela, Carmen ^a   De J Araña, Manuel ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b Center for Biological Research Cuba   (Cuba)

Author keywords

HPV; Human papillomavirus; Interferon ; Interferon ; Interleukin 15; Interleukin 4; Neutralising antibodies

Indexed keywords

HEBERON ALFA; INTERLEUKIN 15; INTERLEUKIN 4; MESSENGER RNA; NEUTRALIZING ANTIBODY; RECOMBINANT ALPHA2B INTERFERON; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ANIMAL CELL; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SENSITIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LARYNX PAPILLOMATOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; STRAIN DIFFERENCE; VIRUS STRAIN; WART VIRUS;

ADULT; ANTIBODIES; BASE SEQUENCE; CHILD; CYTOKINES; DNA PRIMERS; DRUG RESISTANCE; GENE EXPRESSION; HUMANS; INTERFERON ALFA-2B; LARYNGEAL NEOPLASMS; NEUTRALIZATION TESTS; PAPILLOMA; PAPILLOMAVIRIDAE; RNA, MESSENGER;

EID: 0344631689     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mounts P, Shah KV, Respiratory papillomatosis: etiological relation to genital tract papillomaviruses. Prog Med Virol (1984) 29: 90-114.
2. Gissman L, Wolnik L, Ikenberg H et al, Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA (1983) 80: 560-4.
3. Kashima H, Mounts P, Tumors of the head and neck, larynx, lung and esophagus and their possible relation to HPV. In: Papillomaviruses and Human Diseases (ed K Syrjanen, L Gissmann, LG Koss) 138-57. Springer-Verlag, Berlin, 1987.
4. Lundquist PG, Hanglund S, Carlsoo B et al, Interferon therapy in juvenile laryngeal papillomatosis. Otolaryngol Head Neck Surg (1984) 92: 386-9.
5. Stadler RS, Ruszczak Z, Interferons. New additions and indications for use. Dermatol Clin (1993) 11: 187-99.
6. Perea SE, Lopez-Ocejo O, Von Gabain A, Araña MJ, Human papillomavirus type-16 (HPV-16) major transforming proteins functionally interact with interferon signaling mechanisms. Int J Oncol (1997) 11: 169-73.
7. Arany I, Rady P, Tyring SK, Alterations in cytokine/antioncogene expression in skin lesions caused by 'low risk' types human papillomaviruses. Viral Immunol (1993) 6: 255-65.
8. Morelli AE, Belardi G, DiPaola G et al, Cellular subsets and epithelial ICAM-I and HLA DR expression in human papillomavirus infection of the vulva. Acta Derm Venereol (1994) 74: 45-50.
9. Woodworth CD, Waggoner S, Barnes W et al, Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNA exhibit dysplastic differentiation in vivo. Cancer Res (1990) 50: 3709-15.
10. Kawasaki ES, Sample preparation from blood, cells and other fluids. In: PCR Protocols: A Guide to Methods and Applications (ed MA Innis, DH Gelfand, TH White) 146-52. Academic Press, San Diego, 1990.
11. Ting Y, Manos MM, Detection and typing of genital human papillomaviruses. In: PCR Protocols: A Guide to Methods and Applications (ed MA Innis, DH Gelfand, TH White) 146-52. Academic Press, San Diego, 1990.
12. Saiki RK, Gelfand DH, Stoffel S et al, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 239: 487-9.
13. Chomczynski P, Sacchi N, Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 162: 156-9.
14. Jung HC, Eckmann L, Yang S-K et al, A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest (1995) 95: 55-65.
15. Maniatis T, Fritsch EF, Sambrook J, Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1989.
16. Lew DJ, Decker T, Strehlow I, Darnell JE, Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol (1991) 11: 182-91.
17. Sedmak J, Grossberg SE, A rapid, sensitive, and versatile assay for protein using coomassie brilliant blue G250. Anal Biochem (1997) 79: 544-52.
18. González-Cabañas R, Ferrero J, Morales MG, Immunogenicity of recombinant interferon alpha-2b (Heberon alfa R). Antibody detection by an immunoenzymatic assay and antiviral activity neutralization. Biotecnología Aplicada (1998) 15: 71-6.
19. Schellekens H, Ryff JC, Van Der Meide PH, Assay for antibodies to human interferon-α: the need for stardardization. J Interferon Cytokine Res (1997) S1: S5-S8.
20. Meazza R, Verdiani S, Biassoni R et al, Identification of a novel interleukin 15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung carcinoma cell lines. Oncogene (1996) 12: 2187-92.
21. Borstein J, Ben-David G, Atad J et al, Treatment of cervical intraepithelial neoplasia and invasive squamous cell carcinoma by interferon. Obst Gynecol Surv (1993) 84: 251-60.
22. Dueñas L, Alcantud F, Alvarez J et al, Use of interferon-α in laryngeal papillomatosis: eight years of the Cuban National Program. J Laryngol Otol (1997) 111: 134-40.
23. Cielli R, Tyring SK, Interferons in human papillomavirus infection. Antiviral Res (1994) 24: 191-204.
24. Poggi MG, Costa S, Latore P, Systemic beta-interferon treatment of cervical intraepithelial neoplasia. J Exp Clin Cancer Res (1990) 12: S181.
25. Perea SE, López-Ocejo O, García-Milián R, Araña MJ, Expression of human papillomavirus type-16 (HPV-16) E6/E7 oncoproteins impairs IFN-response. J Interferon Cytokine Res (1997) 17: S110.
26. Steinberg BM, Gallagher T, Stoler MH, Abramson AL, Relationship between human papillomavirus types in laryngeal papillomatosis and response to interferon-α. In: Cancer Cells 5/ Papillomaviruses, 403-9. Cold Spring Harbor Laboratory Press, New York, 1987.
27. Arany I, Nagamani K, Tyring SK, Interferon resistance is independent from copy numbers in benign HPV-induced lesions. Anticancer Res (1995) 15: 1003-6.
28. Kast WM, Feltkamp MCW, Ressing ME et al, Cellular immunity against human papillomavirus associated cervical cancer. Semin Virol (1996) 7: 117-23.
29. Pao CC, Lin C-Y, Yao D-S, Tseng C-J, Differential expression of cytokine genes in cervical cancer tissues Biochem Biophys Res Commun (1995) 214: 1146-51.
30. Grabstein K, Eisenman J, Shanebeck K et al, Cloning of a T cell growth factor that interacts with the β chain of interleukin-2 receptor. Science (1994) 264: 965-8.
31. Lollini P, Palmieri G, Dc Giovanni C et al, Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma. Int J Cancer (1997) 71: 732-6.
32. Ogasawara K, Hida S, Azimi N et al, Requirement for IRF-1 in the microenviroment supporting development of natural killer cells. Nature (1998) 391: 700-3.
33. Antonelli G, Giannelli G, Currenti M et al, Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN alpha 2 therapy. Clin Exp Immunol (1996) 104: 384-7.
34. Bonino F, Baldi M, Negro F et al, Clinical relevance of anti-interferon antibodies in the serum of chronic hepatitis C patients treated with interferon-α. J Interferon Cytokine Res (1997) 17: 35-8.